ArticleCureus2022

Concomitant Ruxolitinib and Ibrutinib for Graft-Versus-Host Disease (GVHD): The First Reported Use in Pediatric Patients.

Thomas A Gagliardi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.